Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1082

Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review

Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Boehringer Ingelheim GmbH (Boehringer) carries out research, development, manufacture and sale of pharmaceuticals. The company’s products are used in the treatment of central nervous system, respiratory, cardiovascular, urological and virological disord
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Boehringer Ingelheim GmbH (Boehringer) carries out research, development, manufacture and sale of pharmaceuticals. The company’s products are used in the treatment of central nervous system, respiratory, cardiovascular, urological and virological disorders. It has research and development facilities at seven sites and operates production plants in 13 countries. The company carries out its operations under two reportable segments, namely, Human Pharmaceuticals and Animal Health. The company operates through 145 affiliated companies located throughout the world.

Boehringer Ingelheim GmbH Key Recent Developments

Mar 08, 2013: Zealand Pharma Provides Update On Pipeline Products
Feb 14, 2013: Boehringer Ingelheim Selects ChemAxon To Power Global Cheminformatics Platform
Jan 17, 2013: Boehringer Ingelheim And EFSD Call For Grant Applications In Diabetes Research
Oct 31, 2012: Boehringer Ingelheim Presents Pipeline Highlighting Of Respiratory R&D
Oct 26, 2012: Boehringer Ingelheim To Invest €85m In Dortmund Facility To Double Respimat Production

GlobalData’s Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Boehringer Ingelheim GmbH - Key Facts 5
Boehringer Ingelheim GmbH - Key Employees 6
Boehringer Ingelheim GmbH - Key Employee Biographies 7
Boehringer Ingelheim GmbH - Major Products and Services 8
Boehringer Ingelheim GmbH - Pharmaceutical Pipeline Products Data 10
Boehringer Ingelheim GmbH, Pipeline Products by Therapy Area 10
Boehringer Ingelheim GmbH, Pipeline Products by Development Phase 11
Boehringer Ingelheim GmbH - History 17
Boehringer Ingelheim GmbH - Company Statement 22
Boehringer Ingelheim GmbH - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Affiliate 23
Section 2 – Company Analysis 26
Boehringer Ingelheim GmbH - Business Description 26
Business Description - Animal Health 26
Animal Health - Overview 26
Animal Health - Financials 26
Animal Health - Market View 26
Animal Health - Technology 26
Business Description - Human Pharmaceuticals 27
Human Pharmaceuticals - Overview 27
Human Pharmaceuticals - Financials 27
Human Pharmaceuticals - Market View 27
Human Pharmaceuticals - Technology 27
Boehringer Ingelheim GmbH - Corporate Strategy 28
Boehringer Ingelheim GmbH - SWOT Analysis 29
SWOT Analysis - Overview 29
Boehringer Ingelheim GmbH - Strengths 29
Strength - Broad Product Portfolio 29
Strength - Contract Manufacturing Capabilities 29
Strength - Geographical Diversity 29
Strength - Delivering Value through Innovation 29
Boehringer Ingelheim GmbH - Weaknesses 30
Weakness - Product Recalls 30
Weakness - Pradaxa Lawsuit 30
Boehringer Ingelheim GmbH - Opportunities 30
Opportunity - Growing CRO Industry 30
Opportunity - Market Growth in Emerging Economies 30
Opportunity - Strategic Alliances 31
Boehringer Ingelheim GmbH - Threats 31
Threat - Cost Containment Pressures 31
Threat - Uncertain R&D Outcomes 31
Threat - Stringent Government Regulations 31
Threat - Increased Scrutiny on Imports 32
Boehringer Ingelheim GmbH - Key Competitors 33
Section 3 – Company’s Lifesciences Financial Deals and Alliances 34
Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 34
Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 35
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2007 to YTD 2013 36
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Type, 2007 to YTD 2013 37
Boehringer Ingelheim GmbH, Recent Deals Summary 38
Section 4 – Company’s Recent Developments 39
Boehringer Ingelheim GmbH, Recent Developments 39
Mar 08, 2013: Zealand Pharma Provides Update On Pipeline Products 39
Feb 14, 2013: Boehringer Ingelheim Selects ChemAxon To Power Global Cheminformatics Platform 41
Jan 17, 2013: Boehringer Ingelheim And EFSD Call For Grant Applications In Diabetes Research 41
Oct 31, 2012: Boehringer Ingelheim Presents Pipeline Highlighting Of Respiratory R&D 41
Oct 26, 2012: Boehringer Ingelheim To Invest €85m In Dortmund Facility To Double Respimat Production 43
Oct 01, 2012: Boehringer Ingelheim’s New Project Transfer Program Enables Fast Track To Launch For Biopharmaceuticals 43
Sep 26, 2012: Evotec Receives Milestone Payment As Part Of Discovery Alliance With Boehringer Ingelheim 44
Sep 19, 2012: Ten Pharmaceutical Companies Unite To Accelerate Development Of New Medicines 44
Sep 17, 2012: Boehringer Ingelheim To ShutDown One API Plant In Petersburg, Virginia 45
Sep 12, 2012: Common Application For HIV Patient Assistance Program Expedites Application Process For Lifesaving Drugs 45
Section 5 – Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Boehringer Ingelheim GmbH, Key Facts 5
Boehringer Ingelheim GmbH, Key Employees 6
Boehringer Ingelheim GmbH, Key Employee Biographies 7
Boehringer Ingelheim GmbH, Major Products and Services 8
Boehringer Ingelheim GmbH, Number of Pipeline Products by Therapy Area 10
Boehringer Ingelheim GmbH, Number of Pipeline Products by Development Stage 11
Boehringer Ingelheim GmbH, Pipeline Products By Therapy Area and Development Phase 12
Boehringer Ingelheim GmbH, History 17
Boehringer Ingelheim GmbH, Subsidiaries 23
Boehringer Ingelheim GmbH, Affiliate 23
Boehringer Ingelheim GmbH, Key Competitors 33
Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 34
Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 35
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2007 to YTD 2013 36
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Type, 2007 to YTD 2013 37
Boehringer Ingelheim GmbH, Recent Deals Summary 38

List of Figures
Boehringer Ingelheim GmbH, Pipeline Products by Therapy Area 10
Boehringer Ingelheim GmbH, Pipeline Products by Development Phase 11
Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 34
Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 35
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2007 to YTD 2013 36
Boehringer Ingelheim GmbH, Medical Equipment, Deals by Type, 2007 to YTD 2013 37




...